Multicentre Preclinical Animal Research Team


Preclinical stroke research should learn from the experience of clinical stroke research by seeking a firmer evidence base to inform the process of translation. In recent decades the quality of clinical trials and hence the robustness of their results, not only in stroke but in many other therapeutic areas, has improved tremendously. This was the result of a complementary range of measures including strategies to minimize bias, biostatistical advances, data monitoring and auditing, among others. We propose the development and implementation of a similar international, multicenter 'phase III'-type preclinical trials of promising, novel ischemic stroke therapies to inform the possible transition from animal modeling to clinical trial.

  • Status
  • Completed
  • Project Launch
  • 01 September 2013
  • Project completed
  • 31 August 2015
translational medicine neurological disease stroke